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CONTEXT: Non-specific lymphocytic infiltrates of the 
skin pose difficulties in daily practice in pathol-
ogy. There is still a lack of pathognomonic signs 
for the differential diagnosis between benign and 
malignant lymphocytic infiltrates. 
OBJECTIVE: To evaluate the morphological and immu-
nohistochemical profile of lymphocytic infiltrations 
of the skin according to clinical outcome. 
TYPE OF STUDY: Retrospective; histopathological 
and immunohistochemical analysis.
SETTING: Referral center, university hospital. 
SAMPLE: 28 cases of lymphocytic infiltrates of difficult 
differential diagnosis selected from the records. 
MAIN MEASUREMENTS: Eighteen histological 
variables and the immunophenotypic profile 
were assessed using the CD4, CD8, CD3, CD20 
and CD30 lymphoid markers and compared to 
subsequent follow-up. 
RESULTS: The most common diagnoses were: initial 
mycosis fungoides (eight cases) and drug 
reactions (five cases). Single morphological 
variables did not discriminate between benign 
and malignant infiltrates except for the presence 
of Pautrier-Darier’s microabscesses, which were 
found only in mycosis fungoides (p = 0.015). 
Patterns of superficial and deep infiltration (p = 
0.037) and also the presence of eosinophils (p 
= 0.0207) were more frequently found in benign 
lymphocytic infiltrates. Immunohistochemical 
profile of T-cell subsets showed overlap between 
benign and malignant infiltrates with a predomi-
nance of CD4-positive (helper) lymphocytes in 
the majority of cases. 
CONCLUSIONS: A combination of clinical and 
histological features remains the most reliable 
approach for establishing a definite diagnosis 
in cases of lymphoid skin infiltrates.
KEY WORDS: Cutaneous T-cell lymphoma. Pseudo-
lymphoma. Mycosis fungoides. Immunohisto-
chemistry. Differential diagnosis.
• Ana Cristina Cotta  
• Maria Letícia Cintra  
• Elemir Macedo de Souza  
• Luis Alberto Magna  
• José Vassallo
Introduction
Classic textbooks have described five “L” 
categories for the differential diagnosis of 
lymphocytic infiltrates of the skin: lymphoma, 
lymphocytoma cutis, lupus erythematosus, 
polymorphous light eruption, and Jessner’s 
lymphocytic infiltration of the skin.1 Leprosy, 
syphilis, lichen striatus, necrobiosis lipoidica, 
bite reactions, and the mnemonic “DRUGS” 
categories of dermatophytes, reticular ery-
thematous mucinosis, urticarial stages of bul-
lous pemphigoid, gyrate erythemas, localized 
scleroderma and drug reactions, have been 
added to the list.2 Other differential diagnoses 
include lichenoid purpura, lichen sclerosus et 
atrophicus,3 multiform erythema and psoria-
sis.4 Ackerman’s algorithmic method includes 
mycosis fungoides 23 times in six different 
reaction patterns.5 According to Diaz-Cascajo6 
there is no single reliable criterion that allows 
distinction between inflammation and neo-
plasia in lymphoproliferative skin disorders.6 
Distinction between benign and neoplastic 
skin lymphoid infiltrates is of utmost im-
portance for ensuring adequate therapy and 
prognostic evaluation.
Two recent publications have shown 
divergent opinions regarding the role of the 
immunophenotyping of T-cell subsets as a 
diagnostic tool for cutaneous lymphocytic 
infiltrates. Hudson and Smoller7 stated that a 
simple CD4:CD8-positive lymphocyte ratio 
can be obtained from a cutaneous infiltrate that 
is predominantly comprised of T-cells and that 
this ratio can be used to make a diagnosis of 
mycosis fungoides with a high level of sensitiv-
ity and specificity, on the basis of studies made 
by Izban et al.8 Concomitantly, an opposing 
point of view9 has been put forward, in which 
it is stated that predominance of CD4-positive 
cells is seen in a wide variety of non-neoplastic 
conditions and therefore cannot be used to 
discriminate cutaneous T-cell lymphoma from 
inflammatory dermatoses. The former opinion 
is substantiated by some works,8,10 and the 
latter by others.11,12 Since no consensus has 
been reached in the literature, the purpose of 
the present study was to perform a review of 
the different causes of lymphocytic infiltrates 
of the skin via a retrospective study, with 
emphasis on morphological clues and also 
the role of immunophenotyping in making 
appropriate diagnoses. 
Methods
A retrospective study was made on 
consecutive cases of cutaneous lymphoid 
infiltrates of unknown etiology at the Depart-
ment of Pathology, Universidade Estadual de 
Campinas (Unicamp), Campinas, São Paulo, 
Brazil. From 73 cases studied between 1989 
and 1999, 28 were selected. The inclusion 
criteria were a diagnosis of lymphocytic infil-
trates of the skin presenting some histopatho-
logical findings similar to those described 
for early patch, plaque or late patch mycosis 
fungoides,5 as well as similarity to histopatho-
logical findings of mycosis fungoides variants 
previously described,13 and the availability of 
detailed clinical files and paraffin blocks for 
additional immunohistochemical studies. 
In the cases selected, the definitive diagnosis 
of mycosis fungoides had been established 
clinically and histologically, and was further 
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supported by the course of the disease. For 
patients with mycosis fungoides submitted 
to several biopsies, the earliest ones were 
selected. Only patients posing difficulties 
in the differential diagnosis of lymphoid 
infiltrates were included. Obvious malignant 
high-grade non-Hodgkin lymphomas were 
excluded. Patients suffering from advanced-
stage primary nodal lymphomas with clini-
cally evident involvement of the skin were 
excluded, as well as those with evidence of 
extracutaneous disease appearing within six 
months after the diagnosis, in accordance 
with the criteria of the European Organiza-
tion for Research and Treatment of Cancer 
(EORTC).14 
For each biopsy specimen, slides stained 
with hematoxylin and eosin were assessed for 
eighteen histological criteria, in accordance with 
reaction patterns described by Ackerman and 
others.5,15 These variables, listed in Table 1, were 
judged to be present or absent and were recorded 
by two observers who had no clinical informa-
tion at the time of evaluating these criteria (Maria 
Letícia Cintra, Ana Cristina Cotta).
Paraffin-embedded tissue specimens were 
selected from files and submitted to immuno-
histochemical studies. All immunophenotypic 
studies were performed on histological sec-
tions of 5 µm in thickness. The antibodies 
used were CD4 [clone CD45RO/OPD4 
(Dako-Patts, Carpentiria, USA); dilution 
1:50], CD8 [clone C8/144B (Dako); dilu-
tion 1:50], CD3 [polyclonal (Dako); dilution 
1:50], CD20 [clone L26 (Dako); dilution 
1:100] and CD30 [clone BerH2 (Dako); dilu-
tion 1:20]. A steamer was used as the epitope 
retrieval method and the Envision polymer 
(Dako) was used as the reaction amplifier.
Two of us (José Vassallo, Ana Cristina Cotta) 
evaluated the immunohistochemical sections for 
the percentage of stained cells, without knowl-
edge of the previous diagnosis.
Data were analyzed via the chi-squared and 
Kruskal-Wallis tests respectively for morphologi-
cal and immunohistochemical variables. Statisti-
cal significance was set at p < 0.05.
Results
Patients were grouped according to clinical 
data and follow-up. The groups consisted of: 
mycosis fungoides (8 cases), benign lymphoid 
infiltrates (12 cases) and suspected mycosis 
fungoides (8 cases). The latter category included 
patients under prolonged follow-up presenting 
large-plaque parapsoriasis (4 cases), or incom-
plete clinical and histological findings for my-
cosis fungoides and also incomplete response to 
non-destructive therapies (4 cases).11 
The inflammatory dermatoses found 
were skin allergies due to drugs (5 cases, one 
with prominent photosensitivity), pseudo-
lymphoma (2 cases, one associated with anti-
hypertensive drugs), Jessner’s lymphocytic in-
filtration, neurodermatitis, prurigo nodularis, 
lupus erythematosus, and erythema annulare 
centrifugum (1 case each).
From the eighteen morphological crite-
ria studied, Pautrier-Darier’s microabscesses 
were present only in some of the mycosis 
fungoides patients (3 out of 8 cases; 37.5%) 
(Figure 1). Superficial and deep lymphocytic 
infiltrates were less common among mycosis 
fungoides patients and more prominent in 
benign infiltrates (p = 0.037). The most 
frequent epidermal reaction pattern was 
psoriasiform hyperplasia, which was present 
in about half of cases. There was compact 
hyperkeratosis, or parakeratosis, in 75% of 
the mycosis fungoides cases, but this find-
ing was also common in the groups with 
inflammatory dermatosis and suspected 
lymphoma. Absence of spongiosis was not 
a prominent feature in mycosis fungoides, 
in comparison with the other groups. Su-
perficial perivascular patterns combined 
with interstitial patterns of infiltration 
were present in the majority of patients 
in all groups and band-like subepidermal 
infiltration was present in more than half of 
the mycosis fungoides patients. Prominent 
exocytosis with scant spongiosis was more 
frequent in the lymphoma and suspected 
lymphoma (62.5% and 50.0%) cases than 
in the benign infiltrate cases (30.8%). The 
presence of eosinophils was more common 
in the group of benign lymphocytic infil-
trates (p = 0.0207) (Table 1). 
Table 1. Morphological findings from cutaneous infiltrates of the skin in 28 cases of cutaneous lymphoid infiltrates
Morphologic criteria Diagnosis
Mycosis fungoides
n/total           %
Benign dermatosis
n/total              %
  Parapsoriasis
 n/total         % p value
Band-like infiltration 5/8 62.5 4/12 33.3 2/8 25.0 0.2631
Psoriasiform hyperplasia 4/8 50.0 8/12 67.7 4/8 50.0 0.6778
Spongiosis 2/8 25.0 0/12 0 1/8 12.5 0.2046
Abnormal cornified layer 6/8 75.0 10/12 83.3 4/8 50.0 0.2614
Superficial perivascular 7/8 87.5 11/12 91.7 8/8 100 0.6104
Interstitial infiltration 8/8 100 12/12 100 7/8 87.5 0.2735
Superficial and deep infiltration 0/8 0 7/12 63.6 4/8 50.0 0.0377
Folliculitis and perifolliculitis 2/8 28.6 7/12 63.6 3/8 37.5 0.2916
Nodular infiltration 1/8 14.3 2/12 16.7 1/8 12.5 0.9665
Disproportionate exocytosis 5/8 62.5 4/12 33.3 4/8 50.0 0.4276
Prominent eosinophils 2/8 25.0 7/12 58.3 0/8 0 0.0207
Aligned lymphocytes 5/8 62.5 7/12 58.3 5/8 62.5 0.9753
Lymphocyte halos 5/8 62.5 6/12 50.0 4/8 50.0 0.8357
Pautrier-Darier’s microabscesses 3/8 37.5 0/12 0 0/8 0 0.0150
Atypical lymphocytes 6/8 62.5 7/12 58.3 2/8 25.0 0.2425
Larger intraepidermal  1/8 12.5 3/12 25.0 0/8 0 0.2895
Fibrosis 1/8 12.5 4/12 33.3 3/8 37.5 0.4823
Edema 1/8 12.5 4/12 33.3 1/8 12.5 0.4131
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The immunohistochemical studies dem-
onstrated the presence of a predominant T-cell 
immunophenotype in all the cases selected, 
with less than 30% B-cells in all cases, except 
for one patient with suspected cutaneous 
lymphoma.16 CD30 was negative except for 
two mycosis fungoides cases.
There was prominent helper/inducer 
T-cell (CD4-positive) predominance (Figure 
2), in comparison with suppressor/cytotoxic 
(CD8-positive) stained cells, for all groups. 
The CD4:CD8 ratio was about 4. CD4 
lymphocytes constituted about 80% of 
the infiltrating lymphocytes in all groups. 
Statistical analysis did not show significant 
differences between the groups in relation to 
the CD4/CD8 ratio. There was one mycosis 
fungoides case with predominance of CD8 
lymphocytes (Figure 3 and Table 2).
Discussion
There is a large group of skin diseases 
that are characterized by increased num-
bers of lymphocytic cells. For therapeutic 
purposes, benign hyperplasia needs to be 
distinguished from neoplastic conditions. 
In our material, the most difficult differen-
tial diagnosis was between drug reactions 
and cutaneous T-cell lymphomas. Both are 
more frequent in older patients undergoing 
chronic treatments, especially with anti-hy-
pertensive drugs, and they are also described 
in the etiology of some pseudolymphomas.11 
Another important aspect that must be 
considered in relation to drug reactions is 
their clinical presentation as erythroderma 
simulating Sézary Syndrome. The differen-
tial diagnosis for exfoliative erythroderma is 
always difficult and may not be established 
in about 30% to 40% of such patients.17 
This includes atopic dermatitis, psoriasis, 
pityriasis rubra pilaris, contact dermatitis, 
seborrheic dermatitis, pemphigus foliaceous, 
leukemia and other internal malignancies.17 
In fact, it may be necessary to take several 
biopsies in order to detect definite signs of 
cutaneous lymphoma. Lupus erythemato-
sus and leprosy cases are frequent in our 
daily routine, but only one case presented 
histological findings allowing differential 
diagnosis with mycosis fungoides.
Among the morphological variables 
that were evaluated, Pautrier-Darier’s mi-
croabscesses were present only in mycosis 
fungoides cases and were absent in the other 
groups. Although 100% specific for this 
group of patients, Pautrier-Darier’s micro-
abscesses were present only in 37.5% of our 
Figure 1. Mycosis fungoides: compact orthokeratosis, 
Pautrier-Darier’s microabscess, moderate spongiosis (hema-
toxylin-eosin; 200 x). 
Figure 2. Benign lymphocytic infiltration of the skin: CD4-
positive lymphoid cells (immunoperoxidase; 200 x).
mycosis fungoides cases. The high specific-
ity and low sensitivity of Pautrier-Darier’s 
microabscesses for mycosis fungoides that 
we found is in agreement with previous 
studies reporting frequencies from 4.2% to 
37.5%.4,15,18,19 Prominent eosinophils were 
more frequent within benign lymphoid in-
filtrates. This may reflect the predominance 
of drug reaction cases in this group. The 
pattern of superficial and deep perivascular 
infiltration was more commonly seen in be-
nign lymphocytic infiltrations and suspected 
lymphoma cases. 
The mycosis fungoides patients had 
been submitted to several biopsies. Disease 
progression is related to deeper infiltrates 
but we studied just the initial biopsy speci-
mens. Prominent atypical lymphocytes did 
not discriminate for mycosis fungoides. 
Cerebriform lymphocytes are usually con-
sidered to be discriminating variables4 for 
the diagnosis of mycosis fungoides, but they 
were not prominent in the sections we stud-
ied. This was perhaps because we used the 
early mycosis fungoides biopsies in the cases 
when multiple biopsies had been performed. 
The low percentage of spongiosis within the 
benign infiltrate group may be explained by 
the chronic nature of the selected cases in 
this sample. Superficial, deep and nodular 
infiltrate and folliculitis could not be evalu-
ated in two cases of mycosis fungoides and 
one of benign lymphoid infiltration due to 
scant reticular dermis, and the absence of 
adnexa in one case.
One mycosis fungoides case had lym-
phocytes that were 50% CD30-positive, 
but this did not change the diagnosis to 
CD30-positive large T-cell lymphoma. 
CD30 should be expressed by the majority 
(> 75%) of neoplastic cells, in a consistent 
morphological context, to be included 
in this group.14,20 The absence of CD30 
positivity in the other two groups does 
not characterize CD30 as a marker for 
malignancy, as it may be encountered in 
non-malignant lymphoproliferative dis-
orders6,20,21 and even in association with 
non-lymphoproliferative entities.22
Two studies published in 1999 took 
opposing points of view concerning the role 
of the immunophenotyping of cutaneous 
infiltrates.7,9 A high CD4:CD8 ratio was re-
garded as both sensitive and specific for the 
diagnosis of mycosis fungoides by Hudson 
and Smoller,7 on basis of an earlier study 
by Izban et al.8 In that study,8 35 biopsies 
from 29 mycosis fungoides patients were 
evaluated. They found a CD4:CD8 ratio 
of more than 2:1 in 31 of the 35 sections, 
but no control group results were reported 
in that study. Bakels et al.23 performed a 
semiquantitative estimation of CD8-posi-
tive cells in frozen sections. They found a 
greater admixture of CD8-positive small 
lymphocytes in 11 pseudolymphoma cases 
than in 9 mycosis fungoides cases. No sta-
tistically significant difference between the 
groups was described.23
Nuckols et al.10 also reported that a high 
CD4:CD8 ratio was a helpful tool in the dif-
ferential diagnosis between mycosis fungoides 
and inflammatory conditions. They presented 
a control group composed of spongiosis and 
lichenoid dermatitis patients. Their results 
indicated statistically significant differences 
between the groups but only for intraepi-
dermal lymphocytes. The CD4:CD8 ratio 
in the dermis did not show any difference (p 
= 0.18), and about 95% of the counted cells 
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Table 2. Immunohistochemical studies of 28 cases of cutaneous lymphoid infiltrates
Mycosis fungoides CD4 (%) CD8 (%) CD3 (%) CD30 (%) CD20 (%)
Median 80 20 85 0 10
Mean 72.2 24.4 82.5 7.5 11.2
SD 23.9 25 12.8 17.5 9.9
Min 30 1 60 0 0
Max 100 80 100 50 30
Benign dermatosis
Median 80 20 90 0 10
Mean 75.4 23.9 73.1 0 10
SD 24.5 25.6 30.9 0 9.1
Min 30 1 10 0 0
Max 100 80 100 0 30
Parapsoriasis
Median 80 30 90 0 5
Mean 76.3 37.5 73.8 0 13.8
SD 18.5 24.9 23.3 0 27.2
Min 40 10 40 0 0
Max 100 80 90 0 80
p value 0.9910 0.2403 0.8563 - 0.6412
SD = standard deviation; Min = minimum, Max = maximum.
were in the dermis. This included about 9.6 
CD4 cells and 5.3 CD8 cells in the epidermis 
versus 250.2 CD4 cells and 124.8 CD8 cells 
in the dermis. Therefore, we should consider 
that this finding is much more related to the 
subset of lymphocytes that contribute to the 
phenomenon of epidermotropism than to 
the CD4:CD8 ratio itself. The reason why 
the mean observed was so high was mostly 
because of two mycosis fungoides cases with 
prominent epidermotropism. An estimate of 
the proportion of intraepidermal lymphocytes 
was made for the cases in the present study, but 
the number of cells detected was too small to 
allow adequate statistical analysis and did not 
differ from the CD4-CD8 subtype of T-cells 
identified in the corresponding dermis (data 
not published).
On the other hand, Glusac et al.9 believed 
that predominance of CD4 positive cells is 
seen in a wide variety of non-neoplastic con-
ditions and cannot be used as a discrimina-
tory parameter for the differential diagnosis 
between cutaneous T-cell lymphomas and 
inflammatory dermatoses. Some authors also 
regard the CD4:CD8 ratio as a nonspecific 
finding, given the existence of cases of myco-
sis fungoides with predominant CD8.
CONCLUSIONS
Our results corroborate previous data in 
which it was concluded that the immuno-
phenotypic profile must be considered with 
caution because benign lymphocytic infil-
trates9,11 as well as small plaque parapsoriasis 
biopsy specimens12 may display predominant 
CD4 expression. Definite diagnosis still 
needs clinicopathological correlation and 
careful follow-up. 
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Figure 3. Mycosis fungoides: CD8-positive infiltrating 
lymphocytes (immunoperoxidase; 200 x).
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Avaliação dos critérios diagnósticos nas infiltra-
ções linfocitárias cutâneas
CONTEXTO: Infiltrações linfocitárias não-espe-
cíficas da pele representam dificuldades diag-
nósticas na prática diária da patologia. Não 
há sinais patognomônicos para o diagnóstico 
diferencial entre infiltrações linfocitárias 
benignas e malignas. 
OBJETIVOS: Avaliar o perfil morfológico e 
imunofenotípico das infiltrações linfocitárias 
de acordo com a evolução clínica. 
TIPO DE ESTUDO: Retrospectivo: análise 
histopatológica e imunoistoquímica. 
LOCAL: Centro de referência, hospital univer-
sitário. 
AMOSTRA: 28 casos de infiltrações linfocitárias 
de diagnóstico diferencial difícil selecionados 
dos arquivos. 
PRINCIPAIS MEDIDAS: Análise de 18 variáveis 
histológicas e perfil imunofenotípico utilizando 
os marcadores linfóides CD4, CD8, CD3, CD20 
e CD30, comparados à evolução clínica. 
RESULTADOS: Os diagnósticos mais comuns 
foram: micose fungóide — inicial (oito casos) 
e farmacodermias (cinco casos). Variáveis 
morfológicas isoladas não discriminaram 
infiltrados benignos e malignos, exceto pela 
presença dos microabscessos de Pautrier-
Darier, que foram encontrados apenas na 
micose fungóide (p = 0,015). O padrão de 
infiltração superficial e profunda (p = 0,037) 
e a presença de eosinófilos (p = 0,0207) foram 
mais freqüentes nas infiltrações linfocitárias 
benignas. O perfil imunoistoquímico dos 
linfócitos T mostrou sobreposição entre infil-
trações benignas e malignas, com predomínio 
de linfócitos T auxiliares CD4 positivos na 
maioria dos casos.
CONCLUSÃO: A combinação das informações 
clínicas e histológicas representa a abordagem 
mais consistente para o diagnóstico diferen-
cial dos infiltrados linfóides cutâneos.
PALAVRAS-CHAVE: Linfoma de Células T 
Cutâneo. Pseudolinfoma. Micose fungóide. 
Imunohistoquímica. Diagnóstico diferencial.
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